Treatment of Women With PCOS of Phenotype D

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 14, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

June 30, 2025

Conditions
PCOS (Polycystic Ovary Syndrome)
Interventions
DIETARY_SUPPLEMENT

Diosgenin

Patients will take a tablet containing diosgenin (120 mg), alpha-lactalbumin (100 mg) and vitamin D (50 mcg) - two times per day for six months

Trial Locations (1)

00198

Alma Res Fertility Center, Rome

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Lo.Li.Pharma s.r.l

INDUSTRY

NCT06639698 - Treatment of Women With PCOS of Phenotype D | Biotech Hunter | Biotech Hunter